Table 2.
Serum CCL2 levels of the study subjects after adjusting the data for the covariates of gender and age
| Unadjusted Data (ANOVA) | Adjusted Data (ANCOVA) | |||||||
|---|---|---|---|---|---|---|---|---|
| Serum CCL2 (pg/ml) | Std Error | 95% CI | Estimated Serum CCL2 (pg/ml) | Std Error | 95% CI | |||
| Lower Limit | Upper Limit | Lower Limit | Upper Limit | |||||
| Unexposed (no apparent disease) | 275.2 | 22.9 | 230.2 | 320.3 | 303.5 | 24.2 | 256.0 | 351.1 |
| Possibly Exposed (no apparent disease) | 307.5 | 7.8 | 292.2 | 322.8 | 305.6 | 7.7 | 290.4 | 320.8 |
| Mesothelioma (all patients) | 421.3a,c | 20.8 | 380.5 | 462.1 | 411.8b,c | 20.8 | 370.9 | 452.6 |
aDifferent from the Unexposed (no apparent disease) group at p < 0.001
bDifferent from the Unexposed (no apparent disease) group at p < 0.01
cDifferent from the Possibly Exposed (no apparent disease) group at p < 0.001